The R&D Tax Credit is the biggest tax credit available to U.S. businesses, yet also one of the most underutilized.
Does your business operate in the Pharmaceutical sector?
Transformation and technological development are daily challenges for companies in the pharmaceutical sector. However, resolving many of these technical challenges often qualifies as research and development from a tax perspective and you’re more than likely to be eligible for generous tax relief.
Each of the various phases of the development processes associated with new, improved and generic drug products involve significant time and expenses that qualify toward tax credits, meaning that any pharmaceutical company can take advantage of the credits to reinvest in their business. These activities and expenses can be derived from many categories of qualified R&D activities that fall within the broad scope provided by the R&D Tax Credit framework.
What counts as R&D?
Below is a list of just some of the qualifying activities for the pharmaceutical sector:
- Development and testing of new or improved products, formulas, and compounds
- Support and supervision roles in laboratory or testing processes
- New or improved product trials, including manufacturing methodologies and packaging
- And many more…
We analyze all of your expenses and activities – both past and present – in order to determine the true extent of your eligibility, not just the obvious low-hanging fruit. Download our Pharma R&D Factsheet below to learn more about R&D in the Pharmaceutical sector and see more projects that qualify for R&D tax relief.